About Concur Lives
Concur Lives is a Healthcare company. It offers pharmaceutical solutions for chronic diseases in India and globally. It operates on a B2B model. The company has 61 employees. Its Indian entity Concur Pharmaceuticals Private Limited reported revenue of ₹9.98 Cr. Concur Lives offers products and services including Neurological Drugs, Cardiovascular Products, Orthopedic Solutions, and Gynaecology Medications. Its focus areas include Pharmaceuticals, Cardiovascular, Neurology and Neurological Disorders.
Company details
Concur Pharma, established in 2011 in New Delhi, India, specializes in developing and marketing pharmaceutical products for chronic diseases such as Nephrology, Neurological Disorders, Gynaecology, and Orthopedics. It operates through customer-dedicated marketing teams and comprehensive portfolios, serving healthcare needs in India and 12 other countries. The company focuses on innovative, out-of-the-box solutions to address unmet medical gaps and promote better disease management.
- Employees 61
- SectorsHealthcare
- Phone•••• ••••
- Website concurlives.com
- Social Facebook
- Legal Name Concur Pharmaceuticals Private Limited
- Date of Incorporation 14 Mar, 2011
- Jurisdiction Delhi, India
- Indian entity revenue₹9.98 Cr
FY 2024 · +17% YoY
- Indian entity net profit₹31.1 Lakh
FY 2024 · 3% margin
- Indian entity EBITDA₹49.8 Lakh
FY 2024 · 5% margin
- Employee Count61
Associated legal entities of Concur Lives
Concur Lives operates through Concur Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Concur Pharmaceuticals Private Limited CIN U24100DL2011PTC215797 | Active | 14 Mar 2011 | Delhi, Delhi | ₹10.0 Cr | 61 | 5 | View details |
Products & Services of Concur Lives
Concur Lives offers a comprehensive portfolio of products and services, including Neurological Drugs, Cardiovascular Products, Orthopedic Solutions, and Gynaecology Medications.
Medications for managing neurological disorders effectively.
Treatments for cardiovascular conditions and related health issues.
Products for orthopedic disorders and bone health management.
Drugs addressing gynaecological health and related concerns.
Board of directors of Concur Pharmaceuticals Private Limited (Concur Lives)
Concur Pharmaceuticals Private Limited is the primary company behind Concur Lives. The board of Concur Pharmaceuticals Private Limited currently have 5 directors; the longest-serving is Ajeet Kumar, appointed in 2011. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ajeet Kumar DIN 03376763 | Director | 14 Mar 2011 | 15 yrs 7 mo | Concur Pharmaceuticals Private Limited |
| Amrit Kaushal DIN 05182572 | Director | 16 Jan 2012 | 14 yrs 9 mo | Concur Pharmaceuticals Private Limited |
| Patanjali Kumar DIN 05182576 | Director | 16 Jan 2012 | 14 yrs 9 mo | Concur Pharmaceuticals Private Limited |
| Sandip Hazari DIN 05218370 | Director | 05 Mar 2012 | 14 yrs 7 mo | Concur Pharmaceuticals Private Limited |
| Ravi Shankar Choudhary DIN 05217897 | Director | 05 Mar 2012 | 14 yrs 7 mo | Concur Pharmaceuticals Private Limited |
Financials of Concur Lives
Figures of Concur Pharmaceuticals Private Limited, the primary company behind Concur Lives, for FY 2024. Revenue was ₹9.98 Cr (+17% year on year). Net profit was ₹31.1 Lakh (3% margin). EBITDA was ₹49.8 Lakh (5% margin). Revenue has grown at a compounded annual rate of +12% over three years and +3% over five years.
- ₹9.98 CrRevenue · FY 2024 · +17% YoY
- ₹31.1 LakhNet profit · 3% margin
- ₹49.8 LakhEBITDA · 5% margin
- ₹10 LakhPaid-up capital
- 61Employees (provident fund records)
- +12%Revenue CAGR, 3 years
- +3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Concur Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Concur Lives
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Concur Lives
Concur Lives has 61 employees.
The primary company behind Concur Lives, Concur Pharmaceuticals Private Limited, reported revenue of ₹9.98 Cr for FY 2024, up 17% year on year.
Concur Pharma, established in 2011 in New Delhi, India, specializes in developing and marketing pharmaceutical products for chronic diseases such as Nephrology, Neurological Disorders, Gynaecology, and Orthopedics. It operates through customer-dedicated marketing teams and comprehensive portfolios, serving healthcare needs in India and 12 other countries. The company focuses on innovative, out-of-the-box solutions to address unmet medical gaps and promote better disease management.
Concur Lives offers Neurological Drugs, Cardiovascular Products, Orthopedic Solutions, and Gynaecology Medications.
Concur Lives operates through Concur Pharmaceuticals Private Limited.
The legal entities of Concur Lives currently have 5 directors, including Amrit Kaushal, Patanjali Kumar, Ajeet Kumar and others.